Cyrus Biotechnology, Inc.
Seattle, WA Doing business as Cyrus Biotechnology Inc.
- UEI
- VLHZAL9WY776
- CAGE
- 760V8
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3005 1st Ave Suite 203, Seattle, WA 98121, USA
- Website
- cyrusbio.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Optimization, pharmacokinetics, and efficacy of an IGG protease for the treatment of immune thrombocytopenia and other… | National Institute of Allergy and Infectious Diseases | $600,000 | |
| Advanced uricase engineering for improved outcomes in gout patients - abstract gout, a common form of arthritis… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $298,915 | |
| Optimization of a broad and potent decoy receptor for sars-associated viruses - abstract the spike protein (s) of sars… | National Institute of Allergy and Infectious Diseases | $609,111 | |
| An easy-to-use and powerful tool for improved rosetta comparative modeling of proteins | National Institutes of Health | $224,908 |
About Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. is a minority-owned, small disadvantaged business located in Seattle, Washington, registered in the System for Award Management (SAM) since June 2014. The company specializes in computational protein design and biotechnology research, focusing on developing advanced therapeutic protein solutions for various medical conditions. Through its innovative approach, Cyrus Biotechnology leverages artificial intelligence and computational modeling to engineer protein variants with improved pharmacological characteristics, such as reduced immunogenicity, enhanced stability, and extended half-life.
The company has received multiple federal grant awards from prominent research agencies, including the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). These grants support critical research projects in areas such as developing an immunoglobulin G (IgG) protease enzyme for treating immune thrombocytopenia, engineering uricase variants for gout treatment, and creating a broad decoy receptor for SARS-associated viruses. Specifically, Cyrus Biotechnology has been awarded project grants totaling approximately $598,915, with research focusing on computational protein design, therapeutic protein engineering, and addressing challenging medical conditions. The company's research involves sophisticated techniques like deep mutagenesis, computational modeling to remove antigenic epitopes, and fusion protein strategies to improve protein therapeutics' efficacy and safety.
Quick answers
What is Cyrus Biotechnology, Inc.'s UEI?
Cyrus Biotechnology, Inc.'s Unique Entity ID (UEI) in SAM.gov is VLHZAL9WY776.
What is Cyrus Biotechnology, Inc.'s CAGE code?
Cyrus Biotechnology, Inc.'s CAGE code is 760V8.
What is Cyrus Biotechnology, Inc.'s primary NAICS code?
Cyrus Biotechnology, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cyrus Biotechnology, Inc. located?
Cyrus Biotechnology, Inc.'s physical address in SAM.gov is 3005 1st Ave Suite 203, Seattle, WA 98121, USA.
Is Cyrus Biotechnology, Inc. registered in SAM.gov?
Cyrus Biotechnology, Inc.'s SAM.gov registration expired on August 19, 2026.
What is Cyrus Biotechnology, Inc.'s most recent federal award?
Cyrus Biotechnology, Inc.'s most recent federal grant award is Optimization, pharmacokinetics, and efficacy of an IGG protease for the treatment of immune thrombocytopenia and other… (R43AI188988), from National Institute of Allergy and Infectious Diseases, on December 20, 2024.
On GovTribe
See Cyrus Biotechnology, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors